Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks

Autor: Antonio Landi, Mattia Branca, Pascal Vranckx, Sergio Leonardi, Enrico Frigoli, Dik Heg, Paolo Calabro, Giovanni Esposito, Gennaro Sardella, Carlo Tumscitz, Stefano Garducci, Giuseppe Andò, Ugo Limbruno, Paolo Sganzerla, Andrea Santarelli, Carlo Briguori, Jose M. de la Torre Hernandez, Giovanni Pedrazzini, Stephan Windecker, Marco Valgimigli

Publikováno v: Canadian Journal of Cardiology. 38:1488-1500

The comparative effectiveness of transradial (TRA) compared with transfemoral (TFA) access in acute coronary syndrome (ACS) patients undergoing complex percutaneous coronary intervention (PCI) remains unclear.Among 8404 ACS patients in the Minimising

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1eb3d0846a325624c3a8062ec070ea3
https://doi.org/10.1016/j.cjca.2022.06.014

Prediction of radial crossover in acute coronary syndromes

Autor: Giuseppe Sangiorgi, Felice Gragnano, Luigi Fimiani, Giovanni Esposito, Salvatore Chianese, Shamir R. Mehta, Marco Valgimigli, Sergio Leonardi, Mattia Branca, Enrico Romagnoli, Dik Heg, Emanuele Monda, Pascal Vranckx, David van Klaveren, Giuseppe Gargiulo, Giuseppe Biondi-Zoccai, Paolo Calabrò, Vincenzo Fioretti, Giuseppe Andò, Stephan Windecker, Enrico Frigoli, Dario Di Maio, Sanjit S. Jolly

Publikováno v: EuroIntervention
EuroIntervention, 17(12), E971-E980. EuroPCR

BACKGROUND The radial artery is recommended by international guidelines as the default vascular access in patients with acute coronary syndromes (ACS) managed invasively. However, crossover from radial to femoral access is required in 4-10% of cases

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc2bc228c1a8441064da2c6deb3dd095
https://doi.org/10.4244/eij-d-21-00441

Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial

Autor: Ran Kornowski, Mirvat Alasnag, Carl Schultz, Dik Heg, David Hildick-Smith, Peter Jüni, Bernard Chevalier, Andrés Iñiguez, Yoshinobu Onuma, Felix Mahfoud, Master Dapt investigators, Marco Roffi, Marie-Claude Morice, Goran Stankovic, Antonio Colombo, Enrico Frigoli, Alfredo E. Rodriguez, Aris Moschovitis, Maciej Lesiak, Stephan Windecker, Pim A.L. Tonino, Paul Jau Lueng Ong, Pieter C. Smits, Marco Valgimigli, Pascal Vranckx, Jozef Bartunek, Yukio Ozaki, Jan G.P. Tijssen, Peep Laanmets

Publikováno v: Smits, Pieter C; Frigoli, Enrico; Tijssen, Jan; Jüni, Peter; Vranckx, Pascal; Ozaki, Yukio; Morice, Marie-Claude; Chevalier, Bernard; Onuma, Yoshinobu; Windecker, Stephan; Tonino, Pim A L; Roffi, Marco; Lesiak, Maciej; Mahfoud, Felix; Bartunek, Jozef; Hildick-Smith, David; Colombo, Antonio; Stankovic, Goran; Iñiguez, Andres; Schultz, Carl; ... (2021). Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial. Circulation, 144(15), pp. 1196-1211. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.121.056680
Circulation
Circulation, 144(15), 1196-1211. Lippincott Williams and Wilkins

Supplemental Digital Content is available in the text.
Background: The optimal duration of antiplatelet therapy (APT) in patients at high bleeding risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear. Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc57cb3ee5ab6068b161188955fcc6af
https://doi.org/10.1161/circulationaha.121.056680

IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER DAPT

Autor: Yukio Ozaki, Yoshinobu Onuma, Pieter Smits, Enrico Frigoli, Jan G. Tijssen, Peter Juni, pascal vranckx, Marie C. Morice, Bernard Chevalier, Stephan Windecker, Pim A. Tonino, Marco Roffi, Maciej Lesiak, Felix Mahfoud, Jozef Bartunek, David Hildick-Smith, Antonio Colombo, Goran Stankovic, Andres Iniguez, Carl J. Schultz, Ran Kornowski, Paul JL Ong, Dik Heg, Marco Valgimigli

Publikováno v: Journal of the American College of Cardiology. 81:1309

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f785823d6a95966f66167bc8aa07d55
https://doi.org/10.1016/s0735-1097(23)01753-9

Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest

Autor: Sergio Leonardi, Enrico Frigoli, Felice Gragnano, Giovanni Esposito, Alberto Ranieri De Caterina, Pascal Vranckx, Marco Valgimigli, Paolo Calabrò, Negar Manavifar, Roberto Galea, Stephan Windecker, Lukas Hunziker, Alessandro Spirito, Mikael Sunnåker, Giuseppe Gargiulo

Publikováno v: Revista Española de Cardiología (English Edition). 73:893-901

Introduction and objectives Patients who are vulnerable to hemodynamic or electrical disorders (VP) are often excluded from clinical trials and data on the optimal access-site or antithrombotic treatment are limited. We assessed outcomes of transradi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6b8f175abb027a06743cc9be30a1ce
https://doi.org/10.1016/j.rec.2020.01.005